FIELD: medicine.
SUBSTANCE: group of inventions refers to immunology and medicine, and concerns a method for detecting an autoimmune response to 3-hydroxy-3-methylglutaryl-coenzyme A-reductase protein, a diagnostic technique for myopathy, as well as a method for detecting if it is reasonable to prolong a statin therapy in an individual, involving detection of an autoantibody recognising the above protein. What is also presented is a kit for diagnosing myopathy.
EFFECT: group of inventions makes it possible to detect and identify autoantibodies in an individual suffering muscle pain and weakness; a necessity to terminate the statin therapy and start a suppressive therapy is first to be detected.
32 cl, 8 dwg, 5 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HYSTIDIL-TRNA-SYNTHETASE FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES | 2013 |
|
RU2659423C2 |
| METHODS AND COMPOSITIONS FOR AUTOIMMUNE AND INFLAMMATORY DISEASES TREATMENT | 2012 |
|
RU2639540C2 |
| METHOD OF DETECTING ANTI-TNF PREPARATIONS AND AUTOANTIBODIES | 2010 |
|
RU2571489C2 |
| METHOD FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERE | 2011 |
|
RU2635537C2 |
| METHODS FOR OBTAINING MUSCLE-DERIVED CELLS | 2018 |
|
RU2796929C2 |
| MEDICINAL AGENT "SIMVAGLISIN" WITH HYPOLIPIDEMIC EFFECT | 2006 |
|
RU2308947C1 |
| APPLICATION OF SINGLE DOSE OF CD20-SPECIFIC BINDING MOLECULES | 2006 |
|
RU2421242C2 |
| METHOD FOR DETERMINING ANTI-DRUG ANTIBODY ISOTYPE | 2011 |
|
RU2574976C2 |
| PROFILES OF EXPRESSION OF GENES ASSOCIATED WITH LEAN PHENOTYPE | 2009 |
|
RU2532837C2 |
| ANNEXIN A3 AUTOIMMUNE REGULATION OF PROSTATE CANCER | 2008 |
|
RU2484482C2 |
